Randy Ban Sells 25,584 Shares of Inspire Medical Systems, Inc. (NYSE:INSP) Stock

Inspire Medical Systems, Inc. (NYSE:INSP) insider Randy Ban sold 25,584 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $183.50, for a total value of $4,694,664.00. Following the transaction, the insider now directly owns 7,259 shares of the company’s stock, valued at $1,332,026.50. The trade was a 77.90 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Inspire Medical Systems Stock Down 0.9 %

Inspire Medical Systems stock opened at $178.45 on Thursday. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40. The company has a market capitalization of $5.29 billion, a P/E ratio of 103.15, a PEG ratio of 2.97 and a beta of 1.32. The stock’s 50 day moving average is $188.66 and its 200 day moving average is $192.90.

Inspire Medical Systems (NYSE:INSP) last released its earnings results on Monday, February 10th. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. As a group, equities analysts expect that Inspire Medical Systems, Inc. will post 2.17 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Mutual of America Capital Management LLC increased its position in shares of Inspire Medical Systems by 1.2% during the fourth quarter. Mutual of America Capital Management LLC now owns 4,540 shares of the company’s stock valued at $842,000 after acquiring an additional 55 shares in the last quarter. True Wealth Design LLC boosted its stake in Inspire Medical Systems by 39.0% during the 4th quarter. True Wealth Design LLC now owns 196 shares of the company’s stock valued at $36,000 after purchasing an additional 55 shares during the last quarter. Captrust Financial Advisors increased its holdings in shares of Inspire Medical Systems by 2.0% in the 4th quarter. Captrust Financial Advisors now owns 3,034 shares of the company’s stock worth $562,000 after purchasing an additional 59 shares in the last quarter. MML Investors Services LLC raised its stake in shares of Inspire Medical Systems by 0.9% in the fourth quarter. MML Investors Services LLC now owns 7,941 shares of the company’s stock worth $1,472,000 after purchasing an additional 67 shares during the last quarter. Finally, Mariner LLC lifted its holdings in shares of Inspire Medical Systems by 1.6% during the fourth quarter. Mariner LLC now owns 4,837 shares of the company’s stock valued at $897,000 after purchasing an additional 77 shares in the last quarter. 94.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Wells Fargo & Company decreased their target price on Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a report on Tuesday, February 11th. Royal Bank of Canada restated an “outperform” rating and issued a $260.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, February 11th. Piper Sandler cut their target price on shares of Inspire Medical Systems from $260.00 to $233.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Morgan Stanley decreased their price target on shares of Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating for the company in a research note on Tuesday, February 11th. Finally, Bank of America raised Inspire Medical Systems from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.82.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.